NCT03758196

Renal Sympathetic Denervation From the Adventitia on Resistant Hypertension（RSDARH）

Efficacy and Safety of Renal Sympathetic Denervation From the Adventitia on Resistant Hypertension.

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 126 (estimated)
• Sponsor: Henan Institute of Cardiovascular Epidemiology · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

As one of the most common chronic diseases,The adult prevalence of hypertension is approximately 26.4% at present and will rise to 29.2% by 2025.Renal sympathetic denervation from the intima of renal artery has emerged as a potential treatment for resistant hypertension. However, renal sympathetic nerve are mainly located in the adventitia,and there is no report on renal sympathetic denervation from the adventitia of renal artery.This study is a multicenter,randomized,single-blind study,and aimed to observe the safety and efficacy of radiofrequency ablation of the renal artery from the adventitia on the basis of laparoscopic techniques for patients with resistant hypertension.

Detailed description

This study is a multicenter,randomized,single-blind study,and aimed to observe the safety and efficacy of radiofrequency ablation of the renal artery from the adventitia on the basis of laparoscopic techniques for patients with resistant hypertension.

Conditions

• Resistant Hypertension

Interventions

Type	Name	Description
DEVICE	Radiofrequency ablation instruments	Renal Sympathetic Denervation from the adventitia of renal artery

Timeline

• Start date: 2018-10-31
• Primary completion: 2020-12-31
• Completion: 2021-12-31
• First posted: 2018-11-29
• Last updated: 2020-03-12

Locations

1 site across 1 country: China